Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia

dc.contributorLaissue, Paul
dc.creatorChaparro-Solano, HM
dc.date.accessioned2019-02-20T15:18:25Z
dc.date.available2019-02-20T15:18:25Z
dc.date.created2019-02-20T15:18:25Z
dc.date.issued2019
dc.identifierhttp://repository.urosario.edu.co/handle/10336/19110
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherMaestría en Ciencias con Énfasis en Genética Humana
dc.publisherEscuela de Medicina y Ciencias de la Salud
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.sourceAmerican College of Obstetricians and Gynecologists (Ed.). (2013). Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists. Recuperado de https://www.acog.org/~/media/Task%20Force%20and%20Work%20Group%20Reports/public/HypertensioninPregnancy.pdf
dc.sourceBahassi, E. M., & Stambrook, P. J. (2014). Next-generation sequencing technologies: breaking the sound barrier of human genetics. Mutagenesis, 29(5), 303–310. https://doi.org/10.1093/mutage/geu031
dc.sourceBdolah, Y., Karumanchi, S. A., & Sachs, B. P. (2005). Recent advances in understanding of preeclampsia. Croatian Medical Journal, 46(5), 728–736
dc.sourceBerglund, E. C., Kiialainen, A., & Syvänen, A.-C. (2011). Next-generation sequencing technologies and applications for human genetic history and forensics. Investigative Genetics, 2, 23. https://doi.org/10.1186/2041-2223-2-23
dc.sourceBrinkman-Van der Linden, E. C. M., Hurtado-Ziola, N., Hayakawa, T., Wiggleton, L., Benirschke, K., Varki, A., & Varki, N. (2007). Human-specific expression of Siglec-6 in the placenta. Glycobiology, 17(9), 922–931. https://doi.org/10.1093/glycob/cwm065
dc.sourceBurton, G. J., & Jauniaux, E. (2015). What is the placenta? American Journal of Obstetrics and Gynecology, 213(4 Suppl), S6.e1, S6-8. https://doi.org/10.1016/j.ajog.2015.07.050
dc.sourceBurton, G. J., Jauniaux, E., & Charnock-Jones, D. S. (2010). The influence of the intrauterine environment on human placental development. The International Journal of Developmental Biology, 54(2–3), 303–312. https://doi.org/10.1387/ijdb.082764gb
dc.sourceCaburet, S., Zavadakova, P., Ben-Neriah, Z., Bouhali, K., Dipietromaria, A., Charon, C., … Fellous, M. (2012). Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure. PloS One, 7(3), e33412. https://doi.org/10.1371/journal.pone.0033412
dc.sourceCarlosama, C., Elzaiat, M., Patiño, L. C., Mateus, H. E., Veitia, R. A., & Laissue, P. (2017). A homozygous donor splice-site mutation in the meiotic gene MSH4 causes primary ovarian insufficiency. Human Molecular Genetics, 26(16), 3161–3166. https://doi.org/10.1093/hmg/ddx199
dc.sourceCarlosama, C., Patiño, L. C., Beau, I., Morel, A., Delemer, B., Young, J., … Laissue, P. (2018). A novel mutation in KHDRBS1 in a patient affected by primary ovarian insufficiency. Clinical Endocrinology. https://doi.org/10.1111/cen.13749
dc.sourceCasals, F., Idaghdour, Y., Hussin, J., & Awadalla, P. (2012). Next-generation sequencing approaches for genetic mapping of complex diseases. Journal of Neuroimmunology, 248(1–2), 10–22. https://doi.org/10.1016/j.jneuroim.2011.12.017
dc.sourceCastro, T., Mateus, H. E., Fonseca, D. J., Forero, D., Restrepo, C. M., Talero, C., … Laissue, P. (2013). Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 34(12), 2219–2222. https://doi.org/10.1007/s10072-013-1569-4
dc.sourceCha, J., Sun, X., & Dey, S. K. (2012). Mechanisms of implantation: strategies for successful pregnancy. Nature Medicine, 18(12), 1754–1767. https://doi.org/10.1038/nm.3012
dc.sourceChaabane, C., Coen, M., & Bochaton-Piallat, M.-L. (2014). Smooth muscle cell phenotypic switch: implications for foam cell formation. Current Opinion in Lipidology, 25(5), 374–379. https://doi.org/10.1097/MOL.0000000000000113
dc.sourceChaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014). Pre-eclampsia part 1: current understanding of its pathophysiology. Nature Reviews. Nephrology, 10(8), 466–480. https://doi.org/10.1038/nrneph.2014.102
dc.sourceChen, C. W., Jaffe, I. Z., & Karumanchi, S. A. (2014). Pre-eclampsia and cardiovascular disease. Cardiovascular Research, 101(4), 579–586. https://doi.org/10.1093/cvr/cvu018
dc.sourceChesley, L. C., Annitto, J. E., & Cosgrove, R. A. (1968). The familial factor in toxemia of pregnancy. Obstetrics and Gynecology, 32(3), 303–311.
dc.sourceCnattingius, S., Reilly, M., Pawitan, Y., & Lichtenstein, P. (2004). Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. American Journal of Medical Genetics. Part A, 130A(4), 365–371. https://doi.org/10.1002/ajmg.a.30257
dc.sourceCross, J. C. (2000). Genetic insights into trophoblast differentiation and placental morphogenesis. Seminars in Cell & Developmental Biology, 11(2), 105–113. https://doi.org/10.1006/scdb.2000.0156
dc.sourceCui, Y., Wang, W., Dong, N., Lou, J., Srinivasan, D. K., Cheng, W., … Wu, Q. (2012). Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature, 484(7393), 246–250. https://doi.org/10.1038/nature10897
dc.sourceDawson, L. M., Parfrey, P. S., Hefferton, D., Dicks, E. L., Cooper, M. J., Young, D., & Marsden, P. A. (2002). Familial risk of preeclampsia in Newfoundland: a population-based study. Journal of the American Society of Nephrology: JASN, 13(7), 1901–1906.
dc.sourceDelcour, C., Amazit, L., Patino, L. C., Magnin, F., Fagart, J., Delemer, B., … Beau, I. (2018). ATG7 and ATG9A loss-of-function variants trigger autophagy impairment and ovarian failure. Genetics in Medicine: Official Journal of the American College of Medical Genetics. https://doi.org/10.1038/s41436-018-0287-y
dc.sourceDempfle, A., & Loesgen, S. (2004). Meta-analysis of linkage studies for complex diseases: an overview of methods and a simulation study. Annals of Human Genetics, 68(Pt 1), 69–83.
dc.sourceDiggle, C. P., Parry, D. A., Logan, C. V., Laissue, P., Rivera, C., Restrepo, C. M., … Bonthron, D. T. (2012). Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Human Mutation, 33(8), 1175–1181. https://doi.org/10.1002/humu.22111
dc.sourceDucat, A., Doridot, L., Calicchio, R., Méhats, C., Vilotte, J.-L., Castille, J., … Vaiman, D. (2016). Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia. Scientific Reports, 6, 19196. https://doi.org/10.1038/srep19196
dc.sourceFisher, S. J. (2015). Why is placentation abnormal in preeclampsia? American Journal of Obstetrics and Gynecology, 213(4 Suppl), S115-122. https://doi.org/10.1016/j.ajog.2015.08.042
dc.sourceFong, F. M., Sahemey, M. K., Hamedi, G., Eyitayo, R., Yates, D., Kuan, V., … Walton, R. T. (2014). Maternal genotype and severe preeclampsia: a HuGE review. American Journal of Epidemiology, 180(4), 335–345. https://doi.org/10.1093/aje/kwu151
dc.sourceFonseca, D. J., Rojas, R. F., Vergara, J. I., Ríos, X., Uribe, C., Chávez, L., … Laissue, P. (2013). A severe familial phenotype of Ichthyosis Curth-Macklin caused by a novel mutation in the KRT1 gene. The British Journal of Dermatology, 168(2), 456–458. https://doi.org/10.1111/j.1365-2133.2012.11181.x
dc.sourceFonseca, Dora Janeth, Garzón, E., Lakhal, B., Braham, R., Ojeda, D., Elghezal, H., … Laissue, P. (2012). Screening for mutations of the FOXO4 gene in premature ovarian failure patients. Reproductive Biomedicine Online, 24(3), 339–341. https://doi.org/10.1016/j.rbmo.2011.11.017
dc.sourceFonseca, Dora Janeth, Ojeda, D., Lakhal, B., Braham, R., Eggers, S., Turbitt, E., … Laissue, P. (2012). CITED2 mutations potentially cause idiopathic premature ovarian failure. Translational Research: The Journal of Laboratory and Clinical Medicine, 160(5), 384–388. https://doi.org/10.1016/j.trsl.2012.05.006
dc.sourceFonseca, Dora Janeth, Ortega-Recalde, O., Esteban-Perez, C., Moreno-Ortiz, H., Patiño, L. C., Bermúdez, O. M., … Laissue, P. (2014). BMP15 c.-9C>G promoter sequence variant may contribute to the cause of non-syndromic premature ovarian failure. Reproductive Biomedicine Online, 29(5), 627–633. https://doi.org/10.1016/j.rbmo.2014.07.018
dc.sourceFonseca, Dora Janeth, Patiño, L. C., Suárez, Y. C., de Jesús Rodríguez, A., Mateus, H. E., Jiménez, K. M., … Laissue, P. (2015). Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations. Fertility and Sterility, 104(1), 154-162.e2. https://doi.org/10.1016/j.fertnstert.2015.04.016
dc.sourceFonseca, Dora Janeth, Prada, C. F., Siza, L. M., Angel, D., Gomez, Y. M., Restrepo, C. M., … Laissue, P. (2012). A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. American Journal of Medical Genetics. Part A, 158A(3), 689–693. https://doi.org/10.1002/ajmg.a.35215
dc.sourceForbes, K., & Westwood, M. (2010). Maternal growth factor regulation of human placental development and fetal growth. The Journal of Endocrinology, 207(1), 1–16. https://doi.org/10.1677/JOE-10-0174
dc.sourceForero, D. A., Wonkam, A., Wang, W., Laissue, P., López-Correa, C., Fernández-López, J. C., … Perry, G. (2016). Current needs for human and medical genomics research infrastructure in low and middle income countries. Journal of Medical Genetics, 53(7), 438–440. https://doi.org/10.1136/jmedgenet-2015-103631
dc.sourceGalvez, J. M., Restrepo, C. M., Contreras, N. C., Alvarado, C., Calderón-Ospina, C.-A., Peña, N., … Fonseca, D. J. (2018). Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients. Pharmacogenomics and Personalized Medicine, 11, 169–178. https://doi.org/10.2147/PGPM.S170515
dc.sourceGlotov, A. S., Kazakov, S. V., Vashukova, E. S., Pakin, V. S., Danilova, M. M., Nasykhova, Y. A., … Baranov, V. S. (2018). Targeted sequencing analysis of ACVR2A gene identifies novel risk variants associated with preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1–7. https://doi.org/10.1080/14767058.2018.1449204
dc.sourceGuo, G., Lade, J. A., Wilton, A. N., Moses, E. K., Grehan, M., Fu, Y., … Brennecke, S. P. (1999). Genetic susceptibility to pre-eclampsia and chromosome 7q36. Human Genetics, 105(6), 641–647.
dc.sourceHarrison, G. A., Humphrey, K. E., Jones, N., Badenhop, R., Guo, G., Elakis, G., … Cooper, D. W. (1997). A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. American Journal of Human Genetics, 60(5), 1158–1167.
dc.sourceHayward, C., Livingstone, J., Holloway, S., Liston, W. A., & Brock, D. J. (1992). An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. American Journal of Human Genetics, 50(4), 749–757.
dc.sourceInoue, I., Rohrwasser, A., Helin, C., Jeunemaitre, X., Crain, P., Bohlender, J., … Lalouel, J. M. (1995). A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. The Journal of Biological Chemistry, 270(19), 11430–11436.
dc.sourceJanatpour, M. J., Utset, M. F., Cross, J. C., Rossant, J., Dong, J., Israel, M. A., & Fisher, S. J. (1999). A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Developmental Genetics, 25(2), 146–157. https://doi.org/10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K
dc.sourceJarvenpaa, J., Vuoristo, J. T., Savolainen, E.-R., Ukkola, O., Vaskivuo, T., & Ryynanen, M. (2007). Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 23(6), 351–355. https://doi.org/10.1080/09513590701350291
dc.sourceJohnson, M. P., Fitzpatrick, E., Dyer, T. D., Jowett, J. B. M., Brennecke, S. P., Blangero, J., & Moses, E. K. (2007). Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Molecular Human Reproduction, 13(1), 61–67. https://doi.org/10.1093/molehr/gal095
dc.sourceJohnson, Roten, L., Dyer, T., East, C., Forsmo, S., Blangero, J., … Moses, E. K. (2009). The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Human Genetics, 126(5), 655–666. https://doi.org/10.1007/s00439-009-0714-x
dc.sourceKanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., … Kalluri, R. (2008). Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature, 453(7198), 1117–1121. https://doi.org/10.1038/nature06951
dc.sourceKryukov, G. V., Pennacchio, L. A., & Sunyaev, S. R. (2007). Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. American Journal of Human Genetics, 80(4), 727–739. https://doi.org/10.1086/513473
dc.sourceLaissue, P. (2015). Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing. Molecular and Cellular Endocrinology, 411, 243–257. https://doi.org/10.1016/j.mce.2015.05.005
dc.sourceLaissue, P. (2018). The molecular complexity of primary ovarian insufficiency aetiology and the use of massively parallel sequencing. Molecular and Cellular Endocrinology, 460, 170–180. https://doi.org/10.1016/j.mce.2017.07.021
dc.sourceLaissue, P., Burgio, G., l’Hôte, D., Renault, G., Marchiol-Fournigault, C., Fradelizi, D., … Vaiman, D. (2009). Identification of Quantitative Trait Loci responsible for embryonic lethality in mice assessed by ultrasonography. The International Journal of Developmental Biology, 53(4), 623–629. https://doi.org/10.1387/ijdb.082613pl
dc.sourceLaissue, P., Lakhal, B., Benayoun, B. A., Dipietromaria, A., Braham, R., Elghezal, H., … Veitia, R. A. (2009). Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. Journal of Medical Genetics, 46(7), 455–457. https://doi.org/10.1136/jmg.2008.065086
dc.sourceLaissue, P., Lakhal, B., Vatin, M., Batista, F., Burgio, G., Mercier, E., … Vaiman, D. (2016). Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans. Open Biology, 6(10). https://doi.org/10.1098/rsob.160109
dc.sourceLaissue, P., L’hôte, D., Serres, C., & Vaiman, D. (2009). Mouse models for identifying genes modulating fertility parameters. Animal: An International Journal of Animal Bioscience, 3(1), 55–71. https://doi.org/10.1017/S1751731108003315
dc.sourceLaissue, P., Restrepo, C., & Ortiz, A. (2017). Improving the evaluation of milestones for students completing a clinical genetics elective. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 19(12). https://doi.org/10.1038/gim.2017.62
dc.sourceLakhal, B., Laissue, P., Elghèzal, H., & Fellous, M. (2008). [Genetic analysis of premature ovarian failure: role of forkhead and TGF-beta genes]. Gynecologie, Obstetrique & Fertilite, 36(9), 862–871. https://doi.org/10.1016/j.gyobfe.2008.07.002
dc.sourceLakhal, Besma, Laissue, P., Braham, R., Elghezal, H., Saâd, A., Fellous, M., & Veitia, R. A. (2009). A novel BMP15 variant, potentially affecting the signal peptide, in a familial case of premature ovarian failure. Clinical Endocrinology, 71(5), 752–753. https://doi.org/10.1111/j.1365-2265.2009.03571.x
dc.sourceLakhal, Besma, Laissue, P., Braham, R., Elghezal, H., Saâd, A., Fellous, M., & Veitia, R. A. (2010). BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms? Clinical Endocrinology, 72(3), 425–426. https://doi.org/10.1111/j.1365-2265.2009.03651.x
dc.sourceL’Hôte, D., Laissue, P., Serres, C., Montagutelli, X., Veitia, R. A., & Vaiman, D. (2010). Interspecific resources: a major tool for quantitative trait locus cloning and speciation research. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 32(2), 132–142. https://doi.org/10.1002/bies.200900027
dc.sourceLiang, M., Niu, J., Zhang, L., Deng, H., Ma, J., Zhou, W., … Chen, L. (2016). Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia. Placenta, 40, 52–59. https://doi.org/10.1016/j.placenta.2016.02.015
dc.sourceMaltepe, E., Bakardjiev, A. I., & Fisher, S. J. (2010). The placenta: transcriptional, epigenetic, and physiological integration during development. The Journal of Clinical Investigation, 120(4), 1016–1025. https://doi.org/10.1172/JCI41211
dc.sourceMateus, H. E., Pérez, A. M., Mesa, M. L., Escobar, G., Gálvez, J. M., Montaño, J. I., … Laissue, P. (2017). A first description of the Colombian national registry for rare diseases. BMC Research Notes, 10(1), 514. https://doi.org/10.1186/s13104-017-2840-1
dc.sourceMaynard, S., Epstein, F. H., & Karumanchi, S. A. (2008). Preeclampsia and angiogenic imbalance. Annual Review of Medicine, 59, 61–78. https://doi.org/10.1146/annurev.med.59.110106.214058
dc.sourceMcMaster, M. T., Librach, C. L., Zhou, Y., Lim, K. H., Janatpour, M. J., DeMars, R., … Fisher, S. J. (1995). Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. Journal of Immunology (Baltimore, Md.: 1950), 154(8), 3771–3778.
dc.sourceMiranda-Fernández, M.-C., Ramírez-Oyaga, S., Restrepo, C. M., Huertas-Quiñones, V.-M., Barrera-Castañeda, M., Quero, R., … Cabrera, R. (2018). Identification of a New Candidate Locus for Ebstein Anomaly in 1p36.2. Molecular Syndromology, 9(3), 164–169. https://doi.org/10.1159/000488820
dc.sourceMitropoulos, K., Al Jaibeji, H., Forero, D. A., Laissue, P., Wonkam, A., Lopez-Correa, C., … Patrinos, G. P. (2015). Success stories in genomic medicine from resource-limited countries. Human Genomics, 9, 11. https://doi.org/10.1186/s40246-015-0033-3
dc.sourceMorales-Prieto, D. M., Chaiwangyen, W., Ospina-Prieto, S., Schneider, U., Herrmann, J., Gruhn, B., & Markert, U. R. (2012). MicroRNA expression profiles of trophoblastic cells. Placenta, 33(9), 725–734. https://doi.org/10.1016/j.placenta.2012.05.009
dc.sourceMoses, E. K., Lade, J. A., Guo, G., Wilton, A. N., Grehan, M., Freed, K., … Brennecke, S. P. (2000). A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. American Journal of Human Genetics, 67(6), 1581–1585. https://doi.org/10.1086/316888
dc.sourceMurthi, P., Kalionis, B., Cocquebert, M., Rajaraman, G., Chui, A., Keogh, R. J., … Fournier, T. (2013). Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. Placenta, 34(4), 299–309. https://doi.org/10.1016/j.placenta.2013.01.005
dc.sourceNiño, M. Y., Mateus, H. E., Fonseca, D. J., Kroos, M. A., Ospina, S. Y., Mejía, J. F., … Laissue, P. (2013). Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease. JIMD Reports, 7, 39–48. https://doi.org/10.1007/8904_2012_138
dc.sourceOgden, E., Hildebrand, G. J., & Page, E. W. (1940). Rise of Blood Pressure During Ischemia of the Gravid Uterus. Proceedings of the Society for Experimental Biology and Medicine, 43(1), 49–51. https://doi.org/10.3181/00379727-43-11091P
dc.sourceOjeda, D., Lakhal, B., Fonseca, D. J., Braham, R., Landolsi, H., Mateus, H. E., … Laissue, P. (2011). Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertility and Sterility, 95(8), 2658-2660.e1. https://doi.org/10.1016/j.fertnstert.2011.04.045
dc.sourceOrtega-Recalde, O., Beltrán, O. I., Gálvez, J. M., Palma-Montero, A., Restrepo, C. M., Mateus, H. E., & Laissue, P. (2015). Biallelic HERC1 mutations in a syndromic form of overgrowth and intellectual disability. Clinical Genetics, 88(4), e1-3. https://doi.org/10.1111/cge.12634
dc.sourceOrtega-Recalde, O., Moreno, M. B., Vergara, J. I., Fonseca, D. J., Rojas, R. F., Mosquera, H., … Laissue, P. (2015). A novel TGM1 mutation, leading to multiple splicing rearrangements, is associated with autosomal recessive congenital ichthyosis. Clinical and Experimental Dermatology, 40(7), 757–760. https://doi.org/10.1111/ced.12627
dc.sourceOrtega-Recalde, O., Silgado, D., Fetiva, C., Fonseca, D. J., & Laissue, P. (2016). Transcriptomic analysis of skin in a case of ichthyosis Curth-Macklin caused by a KRT1 mutation. The British Journal of Dermatology, 175(6), 1372–1375. https://doi.org/10.1111/bjd.14969
dc.sourceOrtega-Recalde, Oscar, Fonseca, D. J., Patiño, L. C., Atuesta, J. J., Rivera-Nieto, C., Restrepo, C. M., … Laissue, P. (2013). A novel familial case of diffuse leukodystrophy related to NDUFV1 compound heterozygous mutations. Mitochondrion, 13(6), 749–754. https://doi.org/10.1016/j.mito.2013.03.010
dc.sourceOrtega-Recalde, Oscar, Vergara, J. I., Fonseca, D. J., Ríos, X., Mosquera, H., Bermúdez, O. M., … Laissue, P. (2014). Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology. PloS One, 8(6), e64692. https://doi.org/10.1371/journal.pone.0064692
dc.sourcePatiño, Liliana C., Beau, I., Morel, A., Delemer, B., Young, J., Binart, N., & Laissue, P. (2019). Functional evidence implicating NOTCH2 missense mutations in primary ovarian insufficiency etiology. Human Mutation, 40(1), 25–30. https://doi.org/10.1002/humu.23667
dc.sourcePatiño, Liliana C., Walton, K. L., Mueller, T. D., Johnson, K. E., Stocker, W., Richani, D., … Harrison, C. A. (2017). BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9. The Journal of Clinical Endocrinology and Metabolism, 102(3), 1009–1019. https://doi.org/10.1210/jc.2016-3503
dc.sourcePatiño, Liliana Catherine, Battu, R., Ortega-Recalde, O., Nallathambi, J., Anandula, V. R., Renukaradhya, U., & Laissue, P. (2014). Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis. PloS One, 9(10), e109576. https://doi.org/10.1371/journal.pone.0109576
dc.sourcePatiño, Liliana Catherine, Beau, I., Carlosama, C., Buitrago, J. C., González, R., Suárez, C. F., … Laissue, P. (2017). New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing. Human Reproduction (Oxford, England), 32(7), 1512–1520. https://doi.org/10.1093/humrep/dex089
dc.sourcePatiño, Liliana Catherine, Silgado, D., & Laissue, P. (2017). A potential functional association between mutant BMPR2 and primary ovarian insufficiency. Systems Biology in Reproductive Medicine, 63(3), 145–149. https://doi.org/10.1080/19396368.2017.1291767
dc.sourcePlaks, V., Rinkenberger, J., Dai, J., Flannery, M., Sund, M., Kanasaki, K., … Werb, Z. (2013). Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proceedings of the National Academy of Sciences of the United States of America, 110(27), 11109–11114. https://doi.org/10.1073/pnas.1309561110
dc.sourcePrada, C. F., & Laissue, P. (2014). A high resolution map of mammalian X chromosome fragile regions assessed by large-scale comparative genomics. Mammalian Genome: Official Journal of the International Mammalian Genome Society, 25(11–12), 618–635. https://doi.org/10.1007/s00335-014-9537-8
dc.sourceQuail, M. A., Smith, M., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., … Gu, Y. (2012). A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341. https://doi.org/10.1186/1471-2164-13-341
dc.sourceQuintero-Ronderos, P., & Laissue, P. (2018). The multisystemic functions of FOXD1 in development and disease. Journal of Molecular Medicine (Berlin, Germany), 96(8), 725–739. https://doi.org/10.1007/s00109-018-1665-2
dc.sourceQuintero-Ronderos, P., Mercier, E., Fukuda, M., González, R., Suárez, C. F., Patarroyo, M. A., … Laissue, P. (2017). Novel genes and mutations in patients affected by recurrent pregnancy loss. PloS One, 12(10), e0186149. https://doi.org/10.1371/journal.pone.0186149
dc.sourceQuintero-Ronderos, P., Mercier, E., Gris, J.-C., Esteban-Perez, C., Moreno-Ortiz, H., Fonseca, D. J., … Laissue, P. (2017). THBD sequence variants potentially related to recurrent pregnancy loss. Reproductive Biology and Endocrinology: RB&E, 15(1), 92. https://doi.org/10.1186/s12958-017-0311-0
dc.sourceRabaglino, M. B., Post Uiterweer, E. D., Jeyabalan, A., Hogge, W. A., & Conrad, K. P. (2015). Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension (Dallas, Tex.: 1979), 65(2), 421–429. https://doi.org/10.1161/HYPERTENSIONAHA.114.04481
dc.sourceRajagopalan, S., & Long, E. O. (1999). A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. The Journal of Experimental Medicine, 189(7), 1093–1100
dc.sourceRoten, L. T., Johnson, M. P., Forsmo, S., Fitzpatrick, E., Dyer, T. D., Brennecke, S. P., … Austgulen, R. (2009). Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). European Journal of Human Genetics: EJHG, 17(2), 250–257. https://doi.org/10.1038/ejhg.2008.158
dc.sourceSarker, S., Scholz-Romero, K., Perez, A., Illanes, S. E., Mitchell, M. D., Rice, G. E., & Salomon, C. (2014). Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. Journal of Translational Medicine, 12, 204. https://doi.org/10.1186/1479-5876-12-204
dc.sourceSchmidt, A., Morales-Prieto, D. M., Pastuschek, J., Fröhlich, K., & Markert, U. R. (2015). Only humans have human placentas: molecular differences between mice and humans. Journal of Reproductive Immunology, 108, 65–71. https://doi.org/10.1016/j.jri.2015.03.001
dc.sourceSitras, V., Paulssen, R. H., Grønaas, H., Leirvik, J., Hanssen, T. A., Vårtun, A., & Acharya, G. (2009). Differential placental gene expression in severe preeclampsia. Placenta, 30(5), 424–433. https://doi.org/10.1016/j.placenta.2009.01.012
dc.sourceSkjaerven, R., Vatten, L. J., Wilcox, A. J., Rønning, T., Irgens, L. M., & Lie, R. T. (2005). Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (Clinical Research Ed.), 331(7521), 877. https://doi.org/10.1136/bmj.38555.462685.8F
dc.sourceTakimoto, E., Ishida, J., Sugiyama, F., Horiguchi, H., Murakami, K., & Fukamizu, A. (1996). Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science (New York, N.Y.), 274(5289), 995–998.
dc.sourceThan, N. G., Romero, R., Kim, C. J., McGowen, M. R., Papp, Z., & Wildman, D. E. (2012). Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends in Endocrinology and Metabolism: TEM, 23(1), 23–31. https://doi.org/10.1016/j.tem.2011.09.003
dc.sourceTrapnell, C., & Salzberg, S. L. (2009). How to map billions of short reads onto genomes. Nature Biotechnology, 27(5), 455–457. https://doi.org/10.1038/nbt0509-455
dc.sourceValero-Rubio, D., Jiménez, K. M., Fonseca, D. J., Payán-Gómez, C., & Laissue, P. (2018). Transcriptomic analysis of FUCA1 knock-down in keratinocytes reveals new insights into the pathogenesis of fucosidosis skin lesions. Experimental Dermatology, 27(6), 663–667. https://doi.org/10.1111/exd.13532
dc.sourcevan Dijk, M., Mulders, J., Poutsma, A., Könst, A. A. M., Lachmeijer, A. M. A., Dekker, G. A., … Oudejans, C. B. M. (2005). Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nature Genetics, 37(5), 514–519. https://doi.org/10.1038/ng1541
dc.sourceVatin, M., Bouvier, S., Bellazi, L., Montagutelli, X., Laissue, P., Ziyyat, A., … Gris, J.-C. (2014). Polymorphisms of human placental alkaline phosphatase are associated with in vitro fertilization success and recurrent pregnancy loss. The American Journal of Pathology, 184(2), 362–368. https://doi.org/10.1016/j.ajpath.2013.10.024
dc.sourceVatin, M., Burgio, G., Renault, G., Laissue, P., Firlej, V., Mondon, F., … Ziyyat, A. (2012). Refined Mapping of a Quantitative Trait Locus on Chromosome 1 Responsible for Mouse Embryonic Death. PloS One, 7(8), e43356. https://doi.org/10.1371/journal.pone.0043356
dc.sourceWilliams, P. J., & Broughton Pipkin, F. (2011). The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Practice & Research. Clinical Obstetrics & Gynaecology, 25(4), 405–417. https://doi.org/10.1016/j.bpobgyn.2011.02.007
dc.sourceWinn, V. D., Gormley, M., & Fisher, S. J. (2011). The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface. Pregnancy Hypertension, 1(1), 100–108. https://doi.org/10.1016/j.preghy.2010.12.001
dc.sourceZhou, Y., Genbacev, O., & Fisher, S. J. (2003). The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Annals of the New York Academy of Sciences, 995, 73–83.
dc.sourceZintzaras, E., Kitsios, G., Harrison, G. A., Laivuori, H., Kivinen, K., Kere, J., … Ioannidis, J. P. A. (2006). Heterogeneity-based genome search meta-analysis for preeclampsia. Human Genetics, 120(3), 360–370. https://doi.org/10.1007/s00439-006-0214-1
dc.subjectPreeclampsia
dc.subjectMarcadores moleculares
dc.titleAproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia
dc.typemasterThesis


Este ítem pertenece a la siguiente institución